tirzepatide vs semaglutide differences clinical Tirzepatide as Compared with Semaglutide

Patients receiving MOUNJARO in combination with an insulin secretagogue (e.g., sulfonylurea) or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia [see Adverse Reactions (6.1), Drug Interactions (7.1)]

Faster titration is possible on paper but usually produces enough nausea that patients stop

PMC (review synthesizing phase 1/2 data)

2 In this study, following 36 weeks of therapy with once weekly SC tirzepatide (10 or 15 mg), participants (n = 670) were randomized to continue tirzepatide or switch to placebo for an additional 52 weeks

The Food and Drug Administration is cracking down on websites that claim to sell the underlying chemicals of popular diabetes and obesity drugs like Ozempic, Wegovy, and Zepbound, saying that the websites are selling unapproved and misbranded drug products

The SmPCs recommend that patients should be informed about characteristic symptoms of acute pancreatitis, treatment should be discontinued if pancreatitis is suspected, and should not be restarted if pancreatitis is confirmed